Ryan Yiv is a pharmacist who is specialized in Ambulatory Care in Los Angeles, California. Patients can reach him at 2146 W Adams Blvd, Los Angeles or contact him on 562-494-4983. Active license number of Ryan Yiv is 85050 for Ambulatory Care in California. Ryan Yiv is a licensed pharmacist who has demonstrated specialized knowledge and skill in the provision of integrated, accessible health care services by pharmacists and is accountable for addressing medication needs, developing sustained partnerships with patients, and practicing in the context of family and community.
Complete Profile:
Ryan Yiv speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
Ryan Yiv
Specialization:
Ambulatory Care
Gender:
Male
Location:
2146 W Adams Blvd, Los Angeles, California, 90018-2039
Phone:
562-494-4983
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Ryan Yiv are as mentioned below.
NPI Number:
1326718917
NPI Enumeration Date:
15 Sep, 2021
NPI Last Update On:
04 Oct, 2021
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Ryan Yiv are as mentioned below.
Specialization
License Number
State
Status
Ambulatory Care
85050
California
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
4743 Corsica Dr, Cypress, California
Zip:
90630-3575
Phone Number:
--
Fax Number:
--
Patients can reach Ryan Yiv at 2146 W Adams Blvd, Los Angeles, California or can call on phone at 562-494-4983.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.